Viking Therapeutics Surges to 270th in Daily Rankings with $30.4 Million Turnover

On April 29, 2025, Viking Therapeutics (VKTX) saw a significant surge in trading volume, with a total turnover of $30.4 million, marking a 244.3% increase from the previous day. This substantial rise in trading activity placed VKTX at the 270th position in the daily stock market rankings. The stock price of Viking Therapeutics also experienced a notable increase, rising by 7.71% over the past two days, with a cumulative gain of 11.80%.

Cantor Fitzgerald has initiated coverage on Viking Therapeutics, assigning it an Overweight rating and setting a price target of $104. The firm's analysis is centered around the company's promising pipeline and strategic initiatives, which are expected to drive future growth and value creation for shareholders. This positive outlook from Cantor Fitzgerald has likely contributed to the recent upward momentum in VKTX's stock price, as investors respond favorably to the analyst's bullish stance.